Txoj kev tshawb no Hais tias ultraviolet es ho 97,7% Pib nyob rau hauv tshem tawm pathogens nyob rau hauv tsev kho mob chaw

Siv ultraviolet (UV) tua technology los txo cov kev pheej hmoo ntawm lub tsev kho mob-kis tau kab mob tshem tawm mus rau 97,7 feem pua ​​ntawm pathogens nyob rau hauv kev khiav hauj lwm cov chav (ORS), raws li ib txoj kev tshawb no luam tawm nyob rau hauv lub American Journal ntawm mob Control.

Txoj kev tshawb no soj ntsuam ib tug UV teeb technology platform deployed los ntawm New York raws li PurpleSun uas yuav siv tau rau ib tug ntau ntawm tua daim ntaub ntawv rau ORS, ua siab ntev chav thiab lwm yam kev pab kho mob qhov chaw. Tsis zoo li lwm yam tua kab mob cov cuab yeej, uas muaj xws li tshuaj uas muaj peev xwm coj feeb rau inactivate pathogens thiab lub caij yuav tau tawm cov kab mob nyob rau hauv cov chaw vim tib neeg thiab khoom yuam kev, PurpleSun nce mus txog ntau tej chaw nyob rau hauv vib nas this nrog UV teeb. Txoj kev tshawb no pom tau tias nws tag nrho tab sis eliminates tib neeg thiab khoom yuam kev nyob rau hauv lub loj hlob pathogens uas yuav ua rau kom kis ntawm pathogens uas ua rau kom muaj kab mob.

PurpleSun lub focused multivactor ultraviolet (FMUV) ntaus ntawv yuav ua deployed puag ncig khoom ntawm tag nrho cov sab, nrog foldable partitions uas nws lub teeb hits tsib txawv nto cov ntsiab lus thiab siv feem ntau ntawm cov UV siv nyob rau hauv 90-thib ob Team sib. Ntau tshaj 3,000.microbiological kuaj nram qab no 100 txawv phais mob tau noj nyob rau hauv thiab ib ncig ntawm lub Örs ntawm peb sib txawv tsev kho mob nyob rau hauv lub New York tsam. Lub observational txoj kev tshawb no yog ntseeg kom ua tau tus thawj yuav siv tsib-point multisided zauv nyob rau hauv kev soj ntsuam cov nyhuv ntawm UV tu dej technology.

"Ultraviolet lub teeb technology yuav tsis hloov phau ntawv tu thiab tua nrog tshuaj, tab sis nws yog ib muaj ib qho chaw nyob rau hauv kev kho mob chaw. Qhov no technology yuav optimize tej kev huv, ua rau poob pathogens uas yuav muaj feem ua rau tus kab mob, "hais tias Donna Armellino, RN, DNP, tus lwm thawj ntawm kab mob kev tiv thaiv ntawm Northwell Health thiab cov hlau lead sau ntawm txoj kev tshawb, hu ua:" Assessment ntawm focused multivector ultraviolet tua nrog shadowless tus me nyuam, siv tsib-point multisided zauv ntawm tus neeg mob mob cov khoom tsis muaj phau ntawv tshuaj tua kab. "

Armellino hais tias lub hom phiaj ntawm txoj kev tshawb no yog los mus txiav txim yog tias UV technology thiaj li ib puag ncig pathogens rau lub hom phiaj ntawm kev ua kev kho mob chaw nyob xeeb dua qub thiab kev txhim kho tus neeg mob kev.

Armellino tus co-sau phau ntawv twb Thomas J. Walsh, MD, thiab Vidmantas Petraitis, MD, ob qho tib si ntawm Weill Cornell tshuaj ntawm Cornell University; thiab Wladyslaw Kowalski, PhD, ntawm ntshav tiv tshav ntuj kub

Lub sim siv FMUV twb tau soj xyuas ntawm Long Island Jewish Medical Center nyob hauv New Hyde Park. Northwell lub rau-profit chaw, Muaj tseeb tiag North Enterprises, yog ib tug investor nyob rau hauv PurpleSun. 

Tau qhov twg los: Northwell Health


Post lub sij hawm: FEB-27-2019

WhatsApp Online tham!